0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Statins and Musculoskeletal Adverse Events—Reply

Mitchell H. Katz, MD1; Rita F. Redberg, MD, MSc2
[+] Author Affiliations
1Department of Health Services, Los Angeles County, Los Angeles, California
2Department of Medicine, University of California, San Francisco
JAMA Intern Med. 2014;174(2):302-303. doi:10.1001/jamainternmed.2013.12682.
Text Size: A A A
Published online

Extract

In Reply Dr Finkelstein asks that the Editor “advance the appropriate cautions” about the findings of Mansi et al,1 showing higher rates of musculoskeletal conditions and pain in statin users. His concern is that an unintended consequence of the publication and its associated media coverage is that patients will stop using their medication and jeopardize their health.

With publication of any article suggesting an adverse effect of a medication, there is a risk that patients will make an ill-considered decision to stop using a needed medication. However, we believe that patients and their physicians are best served by publication and discussion of adverse effects of medications. We agree that the results of any observational study, including this one, are subject to confounding. However, the study has the advantage of a large number subjects seen in a real-world setting. The recent Cochrane review of statins for primary prevention of cardiovascular disease concluded that “there was evidence of selective reporting of outcomes, and failure to report adverse events.”2 We hope that publication of this study serves to increase research on the adverse effects of statins and increases discussion between physicians and their patients about the known and potential benefits and risks of these drugs.

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

February 1, 2014
Murray M. Finkelstein, PhD, MD
1Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada
JAMA Intern Med. 2014;174(2):302. doi:10.1001/jamainternmed.2013.12697.
February 1, 2014
Ishak Mansi, MD; Eric M. Mortensen, MD, MSc; Christopher R. Frei, PharmD, MSc
1VA North Texas Health Care System, University of Texas Southwestern Medical Center, Dallas2Department of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas
3College of Pharmacy, The University of Texas at Austin, Austin4Pharmacotherapy Education and Research Center, School of Medicine, University of Texas Health Science Center, San Antonio
JAMA Intern Med. 2014;174(2):303-304. doi:10.1001/jamainternmed.2013.12683.
February 1, 2014
Rene Baudrand, MD; Gordon H. Williams, MD
1Department of Endocrinology, Diabetes, and Hypertension, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
JAMA Intern Med. 2014;174(2):302. doi:10.1001/jamainternmed.2013.12705.
CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Jobs
brightcove.createExperiences();